2026 NPPES data Ph.D. Medical Genetics NPI 1457488025 M.D., PH.D.
Verify on CMS →

HARRY SCHROEDER, M.D., PH.D.

Ph.D. Medical Genetics in BIRMINGHAM, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
755
Medicare Part D claims · 88 beneficiaries · Ph.D. Medical Genetics avg: 984
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

HARRY SCHROEDER, M.D., PH.D. filed 755 Medicare Part D claims in 2023 as a Ph.D. Medical Genetics in BIRMINGHAM, Alabama, prescribing 72% generic.

755
Part D claims, 2023
72%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

HARRY SCHROEDER, M.D., PH.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

755 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about HARRY SCHROEDER, M.D., PH.D.?

Quality data not reported

NPI registry status

Active

Issued 02/28/2007

NPI 1457488025

Primary specialty

Ph.D. Medical Genetics

Rare

357 US NPIs in this specialty

Medicare Part D claims

755 23% vs specialty avg

2023 prescription claims

Specialty avg: 984

Specialty distribution in Alabama

How Ph.D. Medical Genetics compares to other specialties among Alabama providers

Alabama providers

Ph.D. Medical Genetics share within Alabama

1. Ph.D. Medical Genetics42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ph.D. Medical Genetics share within Alabama

Specialty board-certification context

Estimated specialty board-certified rate — Ph.D. Medical Genetics (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ph.D. Medical Genetics ABMS/AOA estimate

Est. board-certified rate (Ph.D. Medical Genetics) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ph.D. Medical Genetics) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

HARRY SCHROEDER, M.D., PH.D. is a Ph.D. Medical Genetics provider practicing in BIRMINGHAM, Alabama, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1457488025. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

HARRY SCHROEDER, M.D., PH.D. appears in the CMS NPPES registry as a Ph.D. Medical Genetics provider holding M.D., PH.D. credentials at 1825 UNIVERSITY BLVD, BIRMINGHAM, AL, 35294, with a listed phone of (205) 934-1522. NPI 1457488025 was issued on 02/28/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHROEDER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 755 prescription claims written by this provider, covering 88 Medicare beneficiaries and totaling roughly $926K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ph.D. Medical Genetics is a narrow specialty nationwide, with 357 enrolled providers across 46 states and an average of 984 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1825 UNIVERSITY BLVD
BIRMINGHAM, AL 35294

Provider Details

NPI 1457488025
Specialty Ph.D. Medical Genetics
Credentials M.D., PH.D.
Gender Male
NPI Issued 02/28/2007

Hospital and facility affiliations

Facilities where HARRY SCHROEDER, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC
BIRMINGHAM, AL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

HARRY SCHROEDER, M.D., PH.D. — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 755 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

755
Total Claims
$926K
Total Drug Cost
88
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
759
Total Day Supply
18,293
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$913K
Generic Drug Cost
$13K
Antibiotic Claims
394

Patient Demographics

Average Patient Age
64.3 years
Avg HCC Risk Score
2.32
Gender Split
85% female / 15% male
Age Distribution
<65: 36, 65-74: 33, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Azithromycin
146
Doxycycline Hyclate
78
Fluconazole
65
Gamunex-C
Immune Globul G/Gly/Iga Avg 46
60
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
55
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
53
Sodium Chloride
0.9 % Sodium Chloride
44
Lidocaine-Prilocaine
Lidocaine/Prilocaine
32
Hizentra
Immun Glob G(Igg)/Pro/Iga 0-50
28
Ciprofloxacin Hcl
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ph.D. Medical Genetics Overview

How HARRY SCHROEDER, M.D., PH.D. fits within the Ph.D. Medical Genetics landscape nationally.

357
Ph.D. Medical Genetics Providers in US
46
States with Ph.D. Medical Genetics
984
Avg Claims per Provider

HARRY SCHROEDER, M.D., PH.D.'s 755 claims are below the specialty average of 984.

Nearby Ph.D. Medical Genetics Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as SCHROEDER.

Compare Ph.D. Medical Genetics nationally: see state-by-state distribution →

Frequently Asked Questions

What is HARRY SCHROEDER, M.D., PH.D.'s specialty?
HARRY SCHROEDER, M.D., PH.D. specializes in Ph.D. Medical Genetics and practices in BIRMINGHAM, Alabama. Credentials: M.D., PH.D..
How much does HARRY SCHROEDER, M.D., PH.D. prescribe under Medicare Part D?
In 2023, HARRY SCHROEDER, M.D., PH.D. wrote 755 Medicare Part D claims totaling $926K in drug costs for 88 beneficiaries.
Where is HARRY SCHROEDER, M.D., PH.D. located?
HARRY SCHROEDER, M.D., PH.D. is located at 1825 UNIVERSITY BLVD, BIRMINGHAM, AL, 35294. Phone: (205) 934-1522.
What is HARRY SCHROEDER, M.D., PH.D.'s NPI number?
HARRY SCHROEDER, M.D., PH.D.'s National Provider Identifier (NPI) is 1457488025, issued on 02/28/2007.
Does HARRY SCHROEDER, M.D., PH.D. prescribe more brand-name or generic drugs?
HARRY SCHROEDER, M.D., PH.D.'s prescribing is 28% brand-name and 72% generic drugs by claim count, with $913K in brand drug costs.
How many Ph.D. Medical Genetics providers are there in the US?
There are 357 Ph.D. Medical Genetics providers across 46 states in the US. The average Ph.D. Medical Genetics provider writes 984 Medicare Part D claims per year.
What drugs does HARRY SCHROEDER, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, HARRY SCHROEDER, M.D., PH.D.'s most frequently prescribed drugs include Azithromycin, Doxycycline Hyclate, Fluconazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does HARRY SCHROEDER, M.D., PH.D. accept Medicare?
HARRY SCHROEDER, M.D., PH.D. appears in CMS Medicare data with 755 Part D claims and 88 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify HARRY SCHROEDER, M.D., PH.D.'s credentials?
HARRY SCHROEDER, M.D., PH.D.'s NPI is 1457488025 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology